For an analytical solution to the cyclic peptide problem, see N Go and HA Scheraga, Macromolecules 6, 273 (1973). For an application to modeling of the cyclic peptide gramicidin S, see M Dygert, N Go and HA Scheraga Macromolecules 8, 750-761, 1975.
Kathleen P. Pratt, Ph.D. Assistant Member Puget Sound Blood Center 921 Terry Avenue Benaroya Research Institute, Rm. 3016 Seattle, WA 98104 ph 206-398-5921 FAX 206-587-6056 email kathle...@psbc.org -----Original Message----- From: pymol-users-boun...@lists.sourceforge.net [mailto:pymol-users-boun...@lists.sourceforge.net] On Behalf Of goldm...@fh.huji.ac.il Sent: Thursday, February 14, 2008 4:18 PM To: pymol-users@lists.sourceforge.net Subject: [PyMOL] trying to build cyclic peptides with PyMOL Hello. I am new to PyMOL. Very easily I succeeded to build a linear peptide, given its sequence. I want to build a cyclic peptide for the same sequence, connecting the C-terminus with the N-terminus. I know that the bond that is created that way is too long - it should be, also, some (automatic/algorithmic) way to rearrange the cyclic structure in order to have an acceptable bond length. Is this possible to do with PyMOL? Thanks for your help. -- Moshe Goldstein ---------------------------------------------------------------- This message was sent using IMP, the Internet Messaging Program. ------------------------------------------------------------------------ - This SF.net email is sponsored by: Microsoft Defy all challenges. Microsoft(R) Visual Studio 2008. http://clk.atdmt.com/MRT/go/vse0120000070mrt/direct/01/ _______________________________________________ PyMOL-users mailing list PyMOL-users@lists.sourceforge.net https://lists.sourceforge.net/lists/listinfo/pymol-users ********************************************************************************* This e-mail and any attachments may contain confidential and privileged information. It has been scanned for viruses. If you are not the intended recipient, please notify the sender immediately by return e- mail, delete this e-mail and destroy any copies. Any dissemination, use, review, disclosure, or distribution of this information by a person other than the intended recipient is unauthorized and may be illegal. ********************************************************************************* **
